ISSN: 2657-7941
Archives of Medical Science - Aging
Current issue Archive About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
 
1/2021
vol. 4
 
Share:
Share:
more
 
 
abstract:
Clinical research

Molecular classification of infiltrating ductal carcinomas in Western Algeria

Hayette Sénia Bensaber
1, 2
,
Ouafa Badre
2
,
Azziz Mohamed Bensnouci
3
,
Samia Khalifa
4
,
Fatima Zohra El Kebir
1
,
Tewfik  Sahraoui
1

1.
Laboratory of Developmental Biology and Differentiation (LBDD), Ahmed ben Bella Oran 1 University, Oran, Algeria
2.
Faculty of Natural and Life Sciences, Department of Applied Molecular Genetics (GMA), Mohamed Boudiaf Oran University of Science and Technology (USTOMB), Oran, Algeria
3.
Pathology Laboratory of the Oran Regional University Military Hospital (HMRUO), Oran, Algeria
4.
Laboratory of Anatomy and Pathological Cytology, University Hospital Establishment, Oran, Algeria
Arch Med Sci Aging 2021; 4: e27–e32
Online publish date: 2021/06/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Breast carcinoma is a heterogeneous pathology. These subtypes are known to vary in terms of risk factors, natural histories and responses to therapies. The prognostic classification based on gene expression and genomic profiling was implemented to refine therapeutic indications and improve patient survival. Our goal is to classify infiltrating channel carcinomas according to their molecular profiles and analyze the different clinicopathological variables of these molecular groups.

Material and methods
We conducted a 24-month retrospective study involving 50 patients recruited from the Oran University Hospital and the Oran Regional Military Hospital. Tumors were analyzed histologically and classified after an immunohistochemical study in groups: luminal A, luminal B, Her2+ and basal-like.

Results
Our study showed the predominance of molecular subtype luminal B (36%) of which 55.56% of these tumors were of Scarff-Bloom-Richardson (SBR) grade II and 44% were of grade III. 55.56% were T2 size followed by T1 size with a percentage of about 33.33%. Axillary ganglionic metastases were found in 88.89% of cases, followed by luminal A (32%) with 62.5% grade III, and 37.5% grade SBR II. Thus 37.5% of these tumors were of stage T2 and T4. Axillary ganglionic metastases were present in 87.5%. The HER2 type (20%) with 60% SBR II grade and 40% grade III. All basal-like tumors represented the highest SBR grade III with a percentage of 100%.

Conclusions
Molecular classification is crucial in the direction of treatment.

keywords:

breast cancer, molecular subtypes, hormonal receptors (RH), HER2 status, proliferation index (Ki67)

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe